Moxifloxacin

Founded in 2004, Shanghai Qiao Chemical Science Co., Ltd. manufactures a wide range of active pharmaceutical ingredients spanning antiviral agents (tenofovir, tenofovir disoproxil fumarate, entecavir), antihistamines (fexofenadine hydrochloride, desloratadine, loratadine), cinchona alkaloids (quinine, quinidine, cinchonine, cinchonidine), opioid antagonists (naloxone and naltrexone hydrochloride), the antibiotic moxifloxacin and sodium fusidate, immunosuppressants tacrolimus and rapamycin, cardiovascular drugs (rosuvastatin calcium, clopidogrel bisulphate), the oncology API docetaxel trihydrate, and antiemetics palonosetron and tropisetron hydrochloride, supported by numerous specialty synthetic intermediates including tropane and quinuclidine derivatives. Categorized under prophylactic biological products and chiral intermediates, the company's R&D work spans both small-scale experimentation and commercial-scale production, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.